BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 14648068)

  • 1. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
    Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.
    Kim HR; Kim K; Lee KH; Kim SJ; Kim J
    Clin Exp Immunol; 2008 May; 152(2):336-44. PubMed ID: 18336591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
    Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
    Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
    Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure.
    Zou Y; Chen T; Han M; Wang H; Yan W; Song G; Wu Z; Wang X; Zhu C; Luo X; Ning Q
    J Immunol; 2010 Jan; 184(1):466-75. PubMed ID: 19949088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.
    Zamai L; Ahmad M; Bennett IM; Azzoni L; Alnemri ES; Perussia B
    J Exp Med; 1998 Dec; 188(12):2375-80. PubMed ID: 9858524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK cells require caspases for activation-induced proliferation and cytokine release but not for cytotoxicity.
    Ussat S; Scherer G; Fazio J; Beetz S; Kabelitz D; Adam-Klages S
    Scand J Immunol; 2010 Nov; 72(5):388-95. PubMed ID: 21039733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
    Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal.
    Yang D; Yaguchi T; Lim CR; Ishizawa Y; Nakano T; Nishizaki T
    Cancer Lett; 2010 May; 291(2):225-9. PubMed ID: 19900759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
    Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells.
    Horinaka M; Yoshida T; Kishi A; Akatani K; Yasuda T; Kouhara J; Wakada M; Sakai T
    FEBS Lett; 2010 Feb; 584(3):577-82. PubMed ID: 19995562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.
    Li T; Yang Y; Hua X; Wang G; Liu W; Jia C; Tai Y; Zhang Q; Chen G
    Cancer Lett; 2012 May; 318(2):154-61. PubMed ID: 22182446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines.
    Cuevas EP; Escribano O; Monserrat J; Martínez-Botas J; Sánchez MG; Chiloeches A; Hernández-Breijo B; Sánchez-Alonso V; Román ID; Fernández-Moreno MD; Guijarro LG
    J Cell Biochem; 2009 Dec; 108(6):1292-301. PubMed ID: 19795387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
    Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
    Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
    J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.